Faculty of 1000 evaluation for Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.

Niki Karavitaki, Georgia Ntali
  • November 2015, Faculty of 1000, Ltd.
  • DOI: 10.3410/f.719747024.793511709

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.3410/f.719747024.793511709

The following have contributed to this page: GEORGIA NTALI

In partnership with:

Contributors